NewLink Genetics (NLNK) Tops Q3 EPS by 20c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts NLNK Hot Sheet
Join SI Premium – FREE
NewLink Genetics (NASDAQ: NLNK) reported Q3 EPS of ($0.20), $0.20 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $2.8 million versus the consensus estimate of $310 thousand.
For earnings history and earnings-related data on NewLink Genetics (NLNK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Uber Q3 profit, revenue beat estimates as gross bookings jump 20%
- Penguin Solutions agrees to sell Cree LED unit to Transom Capital
- Enviri exits Deutsche Bahn contract, expects $19M net gain
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
